Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Relay Therapeutics (RLAY) Return on Equity (2020 - 2026)

Relay Therapeutics has reported Return on Equity over the past 6 years, most recently at 0.0% for Q4 2025.

  • Quarterly Return on Equity changed 0.0% to 0.0% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.0% through Dec 2025, changed 0.0% year-over-year, with the annual reading at 0.0% for FY2025, 0.0% changed from the prior year.
  • Return on Equity was 0.0% for Q4 2025 at Relay Therapeutics, down from 0.0% in the prior quarter.
  • Over five years, Return on Equity peaked at 0.0% in Q1 2021 and troughed at 0.0% in Q4 2021.
  • The 5-year median for Return on Equity is 0.0% (2021), against an average of 0.0%.
  • The largest YoY upside for Return on Equity was 0bps in 2021 against a maximum downside of 0bps in 2021.
  • A 5-year view of Return on Equity shows it stood at 0.0% in 2021, then skyrocketed by 40bps to 0.0% in 2022, then tumbled by -50bps to 0.0% in 2023, then increased by 7bps to 0.0% in 2024, then decreased by -12bps to 0.0% in 2025.
  • Per Business Quant, the three most recent readings for RLAY's Return on Equity are 0.0% (Q4 2025), 0.0% (Q3 2025), and 0.0% (Q2 2025).